Denali Therapeutics Inc (DNLI)

Cash & Short-Term Investments

$710.47M

Quarterly · Period ending: · USD

DNLI logo

DNLI Cash & Short-Term Investments

Latest reported$710.47M
DNLI Quarterly Cash & Short-Term Investments ($178.33M → $710.47M)
High-resolution chart · PNG

DNLI cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
710,471,000
987,684,000
867,879,000
848,204,000
898,952,000
817,926,000
832,331,000
836,559,000
896,044,000
936,869,000
1,034,511,000
1,109,256,000
1,190,987,000
1,288,453,000
1,336,215,000
1,106,055,000
1,068,668,000
957,522,000
865,407,000
1,039,175,000
1,308,931,000
1,413,148,000
1,469,697,000
961,201,000
549,581,000
587,250,000
415,356,000
479,390,000
478,603,000
485,481,000
464,297,000
374,958,000
372,591,000
373,402,000
406,226,000
185,801,000
186,964,000
178,331,000
178,331,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.